388 related articles for article (PubMed ID: 26686342)
1. Alpha-synuclein in gastric and colonic mucosa in Parkinson's disease: Limited role as a biomarker.
Chung SJ; Kim J; Lee HJ; Ryu HS; Kim K; Lee JH; Jung KW; Kim MJ; Kim MJ; Kim YJ; Yun SC; Lee JY; Hong SM; Myung SJ
Mov Disord; 2016 Feb; 31(2):241-9. PubMed ID: 26686342
[TBL] [Abstract][Full Text] [Related]
2. Association of SNCA variants with α-synuclein of gastric and colonic mucosa in Parkinson's disease.
Chung SJ; König IR; Lohmann K; Hinrichs F; Kim J; Ryu HS; Lee HJ; Kim K; Lee JH; Jung KW; Kim MJ; Kim MJ; Kim YJ; Yun SC; Hong SM; Myung SJ; Klein C
Parkinsonism Relat Disord; 2019 Apr; 61():151-155. PubMed ID: 30424941
[TBL] [Abstract][Full Text] [Related]
3. Analysis of colonic alpha-synuclein pathology in multiple system atrophy.
Pouclet H; Lebouvier T; Coron E; Rouaud T; Flamant M; Toulgoat F; Roy M; Vavasseur F; Bruley des Varannes S; Neunlist M; Derkinderen P
Parkinsonism Relat Disord; 2012 Aug; 18(7):893-5. PubMed ID: 22560049
[TBL] [Abstract][Full Text] [Related]
4. Is alpha-synuclein in the colon a biomarker for premotor Parkinson's disease? Evidence from 3 cases.
Shannon KM; Keshavarzian A; Dodiya HB; Jakate S; Kordower JH
Mov Disord; 2012 May; 27(6):716-9. PubMed ID: 22550057
[TBL] [Abstract][Full Text] [Related]
5. Biochemical analysis of α-synuclein extracted from control and Parkinson's disease colonic biopsies.
Corbillé AG; Preterre C; Rolli-Derkinderen M; Coron E; Neunlist M; Lebouvier T; Derkinderen P
Neurosci Lett; 2017 Feb; 641():81-86. PubMed ID: 28126589
[TBL] [Abstract][Full Text] [Related]
6. Alimentary, my dear Watson? The challenges of enteric α-synuclein as a Parkinson's disease biomarker.
Visanji NP; Marras C; Hazrati LN; Liu LW; Lang AE
Mov Disord; 2014 Apr; 29(4):444-50. PubMed ID: 24375496
[TBL] [Abstract][Full Text] [Related]
7. Phosphorylated α-synuclein and phosphorylated tau-protein in sural nerves may contribute to differentiate Parkinson's disease from multiple system atrophy and progressive supranuclear paralysis.
Rong Z; Shen F; Wang Y; Sun L; Wu J; Zhang H; Yuan Y; Jiang W; Li X; Ji P; Zhang K
Neurosci Lett; 2021 Jun; 756():135964. PubMed ID: 34022266
[TBL] [Abstract][Full Text] [Related]
8. Distinct Autoimmune Anti-α-Synuclein Antibody Patterns in Multiple System Atrophy and Parkinson's Disease.
Folke J; Rydbirk R; Løkkegaard A; Salvesen L; Hejl AM; Starhof C; Bech S; Winge K; Christensen S; Pedersen LØ; Aznar S; Pakkenberg B; Brudek T
Front Immunol; 2019; 10():2253. PubMed ID: 31616427
[TBL] [Abstract][Full Text] [Related]
9. Colonic mucosal a-synuclein lacks specificity as a biomarker for Parkinson disease.
Visanji NP; Marras C; Kern DS; Al Dakheel A; Gao A; Liu LW; Lang AE; Hazrati LN
Neurology; 2015 Feb; 84(6):609-16. PubMed ID: 25589666
[TBL] [Abstract][Full Text] [Related]
10. Similar α-Synuclein staining in the colon mucosa in patients with Parkinson's disease and controls.
Antunes L; Frasquilho S; Ostaszewski M; Weber J; Longhino L; Antony P; Baumuratov A; Buttini M; Shannon KM; Balling R; Diederich NJ
Mov Disord; 2016 Oct; 31(10):1567-1570. PubMed ID: 27324838
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic Value of Salivary Real-Time Quaking-Induced Conversion in Parkinson's Disease and Multiple System Atrophy.
Luan M; Sun Y; Chen J; Jiang Y; Li F; Wei L; Sun W; Ma J; Song L; Liu J; Liu B; Pei Y; Wang Z; Zhu L; Deng J
Mov Disord; 2022 May; 37(5):1059-1063. PubMed ID: 35278004
[TBL] [Abstract][Full Text] [Related]
12. Detection of alpha-synuclein conformational variants from gastro-intestinal biopsy tissue as a potential biomarker for Parkinson's disease.
Ruffmann C; Bengoa-Vergniory N; Poggiolini I; Ritchie D; Hu MT; Alegre-Abarrategui J; Parkkinen L
Neuropathol Appl Neurobiol; 2018 Dec; 44(7):722-736. PubMed ID: 29676021
[TBL] [Abstract][Full Text] [Related]
13. Autoimmune antibody decline in Parkinson's disease and Multiple System Atrophy; a step towards immunotherapeutic strategies.
Brudek T; Winge K; Folke J; Christensen S; Fog K; Pakkenberg B; Pedersen LØ
Mol Neurodegener; 2017 Jun; 12(1):44. PubMed ID: 28592329
[TBL] [Abstract][Full Text] [Related]
14. Progression of intestinal permeability changes and alpha-synuclein expression in a mouse model of Parkinson's disease.
Kelly LP; Carvey PM; Keshavarzian A; Shannon KM; Shaikh M; Bakay RA; Kordower JH
Mov Disord; 2014 Jul; 29(8):999-1009. PubMed ID: 24898698
[TBL] [Abstract][Full Text] [Related]
15. Brain alpha-synuclein accumulation in multiple system atrophy, Parkinson's disease and progressive supranuclear palsy: a comparative investigation.
Tong J; Wong H; Guttman M; Ang LC; Forno LS; Shimadzu M; Rajput AH; Muenter MD; Kish SJ; Hornykiewicz O; Furukawa Y
Brain; 2010 Jan; 133(Pt 1):172-88. PubMed ID: 19903734
[TBL] [Abstract][Full Text] [Related]
16. α-Synuclein in blood exosomes immunoprecipitated using neuronal and oligodendroglial markers distinguishes Parkinson's disease from multiple system atrophy.
Dutta S; Hornung S; Kruayatidee A; Maina KN; Del Rosario I; Paul KC; Wong DY; Duarte Folle A; Markovic D; Palma JA; Serrano GE; Adler CH; Perlman SL; Poon WW; Kang UJ; Alcalay RN; Sklerov M; Gylys KH; Kaufmann H; Fogel BL; Bronstein JM; Ritz B; Bitan G
Acta Neuropathol; 2021 Sep; 142(3):495-511. PubMed ID: 33991233
[TBL] [Abstract][Full Text] [Related]
17. Enteric GFAP expression and phosphorylation in Parkinson's disease.
Clairembault T; Kamphuis W; Leclair-Visonneau L; Rolli-Derkinderen M; Coron E; Neunlist M; Hol EM; Derkinderen P
J Neurochem; 2014 Sep; 130(6):805-15. PubMed ID: 24749759
[TBL] [Abstract][Full Text] [Related]
18. No enhanced (p-) α-synuclein deposition in gastrointestinal tissue of Parkinson's disease patients.
Harapan BN; Frydrychowicz C; Classen J; Wittekind C; Gradistanac T; Rumpf JJ; Mueller W
Parkinsonism Relat Disord; 2020 Nov; 80():82-88. PubMed ID: 32971383
[TBL] [Abstract][Full Text] [Related]
19. Detection of α-synuclein oligomers in red blood cells as a potential biomarker of Parkinson's disease.
Wang X; Yu S; Li F; Feng T
Neurosci Lett; 2015 Jul; 599():115-9. PubMed ID: 25998655
[TBL] [Abstract][Full Text] [Related]
20. Feasibility and Safety of Multicenter Tissue and Biofluid Sampling for α-Synuclein in Parkinson's Disease: The Systemic Synuclein Sampling Study (S4).
Chahine LM; Beach TG; Seedorff N; Caspell-Garcia C; Coffey CS; Brumm M; Adler CH; Serrano GE; Linder C; Mosovsky S; Foroud T; Riss H; Ecklund D; Seibyl J; Jennings D; Arnedo V; Riley L; Dave KD; Mollenhauer B;
J Parkinsons Dis; 2018; 8(4):517-527. PubMed ID: 30248065
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]